Brian Wolpin Celebrates FDA Approval of Daraxonrasib in Pancreatic Cancer as the Future of the Field
Why Roswell Park Should Consult on Elevated PSA Levels
Meet the Team: Helen Cui, MD, PhD
Adrenal Tumor Patients Need the Multidisciplinary Care Roswell Park Provides
Roswell Park Only Hospital in Region Offering SBRT for Prostate Cancer
Could milk-derived nanoparticles change bile duct cancer care?
2025 ATA Management Guidelines for Adult Patients with Differentiated Thyroid Cancer: Updates from the Endocrinology Perspective
Updates in Breast Cancer Surgery
Treatment Guideline: First-Line Treatment for Metastatic Triple-Negative Breast Cancer (TNBC)
Turning Point focused on Women's Cancers
Treatment Guideline: Vaginal Estrogen in Patients with History of Breast Cancer
UCI Health Chao Family Comprehensive Cancer Center Annual Report 2025
Advancing Oncology Care
Treatment Guideline: Inavolisib, Palbociclib, and Fulvestrant for Hormone Receptor-Positive/HER2-negative Metastatic Breast Cancer
Rare Inherited EGFR Mutation Linked to Dramatically Increased Lung Cancer Risk
The Storied Career Of Clinical Physicist Dr. Charlie Ma: From Philadelphia To Cancer Centers Worldwide
Building a System of Focused Care for Lobular Breast Cancer
Dana-Farber/Boston Children's Named the Top Pediatric Cancer Program in the Nation for 2026-2027
Dana-Farber Science Backs Development of Targeted Therapy for Rare GIST Cancer
Targeting CDK2 Could Boost Immunotherapy Response in Patients With a Wide Range of Cancers, According to Dana-Farber Science
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
